Asako Harada

419 total citations
18 papers, 177 citations indexed

About

Asako Harada is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Asako Harada has authored 18 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Asako Harada's work include DNA Repair Mechanisms (9 papers), Carcinogens and Genotoxicity Assessment (8 papers) and DNA and Nucleic Acid Chemistry (5 papers). Asako Harada is often cited by papers focused on DNA Repair Mechanisms (9 papers), Carcinogens and Genotoxicity Assessment (8 papers) and DNA and Nucleic Acid Chemistry (5 papers). Asako Harada collaborates with scholars based in United States, Japan and Switzerland. Asako Harada's co-authors include Masayuki Mishima, Kenji Tanaka, Mariko Yano, Takahito Yazaki, Takeshi Kawase, Keiichi Uyemura, Saori Matsuo, Toshiko Hara, Takehiko Nohmi and Kenji Tanaka and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Toxicology and Applied Pharmacology and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Asako Harada

17 papers receiving 172 citations

Peers

Asako Harada
Akiko Ukai Japan
Antara Biswas United States
Supriya V. Vartak India
Zih-Jie Shen United States
Polina Gervas Russia
Timothy Budden Australia
George J. Delinasios Greece
Masayuki Kusakabe Japan
Ewan M. McNeil United Kingdom
Fuming Lian China
Akiko Ukai Japan
Asako Harada
Citations per year, relative to Asako Harada Asako Harada (= 1×) peers Akiko Ukai

Countries citing papers authored by Asako Harada

Since Specialization
Citations

This map shows the geographic impact of Asako Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asako Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asako Harada more than expected).

Fields of papers citing papers by Asako Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asako Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asako Harada. The network helps show where Asako Harada may publish in the future.

Co-authorship network of co-authors of Asako Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Asako Harada. A scholar is included among the top collaborators of Asako Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asako Harada. Asako Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Katada, Hitoshi, et al.. (2023). Preclinical <i>in vitro</i> evaluation of immune suppression induced by GYM329, Fc-engineered sweeping antibody. The Journal of Toxicological Sciences. 48(7). 399–409.
2.
3.
Sasaki, Masanori, Asako Harada, Toshiko Hara, et al.. (2019). Daily ascending dosing in cynomolgus monkeys to mitigate cytokine release syndrome induced by ERY22, surrogate for T-cell redirecting bispecific antibody ERY974 for cancer immunotherapy. Toxicology and Applied Pharmacology. 379. 114657–114657. 10 indexed citations
4.
5.
Harada, Asako, et al.. (2018). Different players generate positive responses in two in vitro cytokine assay formats with aqueous and immobilized TGN1412 analog. Biochemical and Biophysical Research Communications. 502(1). 91–97. 2 indexed citations
6.
Tanaka, Kenji, et al.. (2018). Advantages of evaluating γH2AX induction in non-clinical drug development. Genes and Environment. 40(1). 10–10. 21 indexed citations
7.
Tanaka, Kenji, et al.. (2017). Giemsa-stained pseudo-micronuclei in rat skin treated with vitamin D3 analog, pefcalcitol. Genes and Environment. 39(1). 17–17. 5 indexed citations
8.
Harada, Asako, Toshiko Hara, Tomoaki Inoue, et al.. (2016). Is an <i>in vitro</i> whole blood cytokine assay useful to detect the potential risk of severe infusion reaction of monoclonal antibody pharmaceuticals?. The Journal of Toxicological Sciences. 41(4). 523–531. 6 indexed citations
9.
Harada, Asako, et al.. (2014). HSP90 inhibitor CH5164840 induces micronuclei in TK6 cells via an aneugenic mechanism. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 773. 9–13. 2 indexed citations
10.
Harada, Asako, et al.. (2014). The predominant role of apoptosis in γH2AX formation induced by aneugens is useful for distinguishing aneugens from clastogens. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 771. 23–29. 21 indexed citations
11.
Harada, Asako, et al.. (2013). Fluorescent dye-based simple staining for in vivo micronucleus test with flow cytometer. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 751(2). 85–90. 4 indexed citations
12.
Harada, Asako, et al.. (2013). New DNA probes to detect aneugenicity in rat bone marrow micronucleated cells by a pan-centromeric FISH analysis. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 755(1). 73–80. 6 indexed citations
13.
Tanaka, Kenji, Asako Harada, Mariko Yano, et al.. (2012). Lack of Mutagenicity of SMD-502, a New Vitamin D3 Analog for Topical Application, in Skin and Liver of gpt delta Transgenic Mice and in GDL1 Cells. Genes and Environment. 34(3). 107–114. 4 indexed citations
14.
Harada, Asako, et al.. (2010). Whole cell-ELISA to measure the γH2AX response of six aneugens and eight DNA-damaging chemicals. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 700(1-2). 71–79. 38 indexed citations
15.
Mishima, Masayuki, Kenji Tanaka, Asako Harada, et al.. (2008). Two structurally distinct inhibitors of glycogen synthase kinase 3 induced centromere positive micronuclei in human lymphoblastoid TK6 cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 643(1-2). 29–35. 9 indexed citations
16.
Mishima, Masayuki, et al.. (2007). Mutation Spectra in Cisplatin- and Transplatin-treated GDL1 Cells Clarified the Different Mode of Action of These Compounds in Mammalian Cells. Genes and Environment. 29(3). 89–99. 3 indexed citations
17.
Mishima, Masayuki, Kenji Tanaka, Asako Harada, et al.. (2006). A newly established GDL1 cell line from gpt delta mice well reflects the in vivo mutation spectra induced by mitomycin C. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 609(1). 102–115. 10 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akiko Ukai Breakdown of academic impact, for papers by Antara Biswas Breakdown of academic impact, for papers by Supriya V. Vartak Breakdown of academic impact, for papers by Zih-Jie Shen Breakdown of academic impact, for papers by Polina Gervas Breakdown of academic impact, for papers by Timothy Budden Breakdown of academic impact, for papers by George J. Delinasios Breakdown of academic impact, for papers by Masayuki Kusakabe Breakdown of academic impact, for papers by Ewan M. McNeil Breakdown of academic impact, for papers by Fuming Lian
Rankless by CCL
2026